USPTO ensures robust and reliable patents through examiner training on searching for prior art in FDA and NIH databases

[[VIEW_THIS]]

USPTO Alert

USPTO ensures robust and reliable patents through examiner training on searching for prior art in FDA and NIH databases

The United States Patent and Trademark Office (USPTO) works closely with the U.S. Food and Drug Administration (FDA) on a number of collaboration initiatives, including providing training to patent examiners so they have the key information needed when deciding whether to grant patent rights.

As part of our commitment to ensure robust and reliable patent rights for biotech and pharmaceutical inventions, we developed USPTO training materials on searching for prior art in FDA and National Institutes of Health (NIH) databases. These training materials were presented to the public at the Biotechnology, Chemical, and Pharmaceutical Partnership Meeting on March 19, 2024.

We also plan to provide additional examiner training and guidance this year to biotech and pharmaceutical patent examiners on examination of declaratory evidence of unexpected results.

To learn more, visit the USPTO-FDA Collaboration Initiatives webpage.

​​​

Stay connected with the USPTO by subscribing to regular email updates.

Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.

This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov.